Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Evidence-Based Complementary and Alternative Medicine, enter your email address in the box below.

Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 259523, 5 pages
http://dx.doi.org/10.1155/2012/259523
Review Article

Anti-Lung-Cancer Activity and Liposome-Based Delivery Systems of β-Elemene

Meiwan Chen,1 Jinming Zhang,1 Siqin Yu,2 Shengpeng Wang,1 Zaijun Zhang,1,3 Jianqiang Chen,4 Jian Xiao,4 and Yitao Wang1

1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China
2Beijing DDS-Venturepharm .T. Corp, Beijing 100097, China
3Institute of New Drug Research, Guangdong Province Key Laboratory of Pharmacodynamic, Constituents of Traditional Chinese Medicine & New Drug Research, College of Pharmacy, Jinan University, Guangdong 510632, China
4School of Pharmacy, Cixi Hospital, Wenzhou Medical College, Wenzhou 325035, China

Received 20 August 2012; Revised 29 October 2012; Accepted 2 November 2012

Academic Editor: Yoshiyuki Kimura

Copyright © 2012 Meiwan Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, E. Ward, O. Brawley, and A. Jemal, “Cancer statistics, 2011,” A Cancer Journal For Clinicians, vol. 61, no. 4, pp. 212–236, 2011. View at Google Scholar
  2. C. Eheman, S. J. Henley, R. Ballard-Barbash et al., “Annual Report to the Nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity,” Cancer, vol. 118, no. 9, pp. 2338–2366, 2012. View at Google Scholar
  3. P. J. Souquet, F. Chauvin, J. P. Boissel et al., “Polychemotherapy in advanced non small cell lung cancer: a meta-analysis,” The Lancet, vol. 342, no. 8862, pp. 19–21, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. D. H. Johnson, “Evolution of cisplatin-based chemotherapy in non-small cell lung cancer: a historical perspective and the eastern cooperative oncology group experience,” Chest, vol. 117, supplement 1, no. 4, pp. 133S–137S, 2000. View at Google Scholar · View at Scopus
  5. S. Ozkaya, S. Findik, A. G. Atici, and A. Dirica, “Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients,” Neoplasma, vol. 58, no. 4, pp. 348–351, 2011. View at Google Scholar
  6. J. M. A. Nabholtz, D. M. Reese, M. A. Lindsay, and A. Riva, “Combination chemotherapy for metastatic breast cancer,” Expert Review of Anticancer Therapy, vol. 2, no. 2, pp. 169–180, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Zhao, J. E. Kim, E. Reed, and Q. Q. Li, “Molecular mechanism of antitumor activity of taxanes in lung cancer (review),” International Journal of Oncology, vol. 27, no. 1, pp. 247–256, 2005. View at Google Scholar · View at Scopus
  8. C. J. Hu, X. L. Zhao, H. Y. Hu, and Y. F. Xie, “Preparation and characterization of β-elemene microemulsion,” Journal of Shenyang Pharmaceutical University, no. 6, pp. 415–422, 2009. View at Google Scholar
  9. G. Z. Li, “The basic research and clinical application of beta-elemene,” Journal of Changchun University of Traditional Chinese Medicine, pp. 185–186, 2001. View at Google Scholar
  10. C. Y. Xie, W. Yang, J. Ying et al., “B-cell lymphoma-2 over-expression protects. DELTA. Elemene-induced apoptosis in human lung carcinoma mucoepidermoid cells via a nuclear factor kappa B-related pathway,” Biological and Pharmaceutical Bulletin, vol. 34, no. 8, pp. 1279–1286, 2011. View at Google Scholar
  11. J. F. Ju, W. P. Yu, C. S. Fu, and L. M. Ma, “Modern research and clinical application of β-elemene,” Qilu Pharmaceutical Affairs, no. 9, 2008. View at Google Scholar
  12. Q. Jianjun, Z. Song, L. Yin, Z. Jia, and L. Donglei, “Treatment of chylothorax with elemene,” Thoracic and Cardiovascular Surgeon, vol. 56, no. 2, pp. 103–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Q. Li, G. Wang, E. Reed, L. Huang, and C. F. Cuff, “Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy,” Basic and Clinical Pharmacology and Toxicology, vol. 107, no. 5, pp. 868–876, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Wang, X. Li, F. Huang et al., “Antitumor effect of β-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death,” Cellular and Molecular Life Sciences, vol. 62, no. 7-8, pp. 881–893, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Chen, Y. Lu, J. Wu, M. Gao, A. Wang, and B. Xu, “Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis,” Cancer Chemotherapy and Pharmacology, vol. 67, no. 4, pp. 799–808, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. Jun, “The experimential research of reverse to human lung cancer cells by elemene emulsion [J],” Cancer Research on Prevention and Treatment, no. 5, 1996. View at Google Scholar
  17. X. Peng, Y. Zhao, X. Liang et al., “Assessing the quality of RCTs on the effect of β-elemene, one ingredient of a Chinese herb, against malignant tumors,” Contemporary Clinical Trials, vol. 27, no. 1, pp. 70–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. L. Zhao, X. X. Peng, Y. D. Wang, and S. Q. Cui, “Elemene injections for pulmonary cancer: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 5, no. 3, pp. 216–228, 2005. View at Google Scholar · View at Scopus
  19. H. Yang, X. Wang, and L. Yu, “The antitumor activity of elemene is associated with apoptosis,” Chinese Journal of Oncology, vol. 18, no. 3, pp. 169–172, 1996. View at Google Scholar · View at Scopus
  20. S. L. Yefimova, I. Y. Kurilchenko, T. N. Tkacheva et al., “Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells,” Experimental Oncology, vol. 34, no. 2, pp. 101–106, 2012. View at Google Scholar
  21. J. H. Fendler, Membrane Mimetic Chemistry: Characterizations and Applications of Micelles, Microemulsions, Monolayers, Bilayers, Vesicles, Host-Guest Systems, and Polyions, John Wiley & Sons, New York, NY, USA, 1982.
  22. D. Thacharodi and K. P. Rao, “Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride,” Biomaterials, vol. 16, no. 2, pp. 145–148, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Q. Li, G. Wang, M. Zhang, C. F. Cuff, L. Huang, and E. Reed, “β-elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis,” Oncology Reports, vol. 22, no. 1, pp. 161–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Wang, X. Li, F. Huang et al., “Antitumor effect of β-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death,” Cellular and Molecular Life Sciences, vol. 62, no. 7-8, pp. 881–893, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Liu, X. J. Hu, B. Jin, X. J. Qu, K. Z. Hou, and Y. P. Liu, “β-elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells,” Journal of Pharmacy and Pharmacology, vol. 64, no. 1, pp. 146–153, 2012. View at Google Scholar
  26. L. Li, L. Xu, X. Qu et al., “Cbl-regulated Akt and ERK signals are involved in beta-elemene-induced cell apoptosis in lung cancer cells,” Molecular Medicine Reports, vol. 4, no. 6, pp. 1243–1246, 2011. View at Google Scholar
  27. H. Jiang, S. Ma, and J. Feng, “In vitro study of radiosensitization by β-Elemene in A549 cell line from adenocarcinoma of lung,” The Chinese-German Journal of Clinical Oncology, vol. 8, no. 1, pp. P12–P15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Q. Li, B. B. Xie, X. L. Li et al., “Down-regulation of survivin and hypoxia-inducible factor-1α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft,” Cancer Biotherapy and Radiopharmaceuticals, vol. 27, no. 1, pp. 56–64, 2012. View at Google Scholar
  29. F. Zhang, L. Xu, X. Qu et al., “Synergistic antitumor effect of β-elemene and etoposide is mediated via induction of cell apoptosis and cell cycle arrest in non-small cell lung carcinoma cells,” Molecular Medicine Reports, vol. 4, no. 6, pp. 1189–1193, 2011. View at Google Scholar
  30. Y. F. Zhao, C. R. Wang, Y. M. Wu, S. L. Ma, Y. Ji, and Y. J. Lu, “P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment,” Biomedicine and Pharmacotherapy, vol. 65, no. 3, pp. 151–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Zhao, Q. Q. Li, B. Zou et al., “In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma,” International Journal of Oncology, vol. 31, no. 2, pp. 241–252, 2007. View at Google Scholar · View at Scopus
  32. J. M. H. Kremer, M. W. J. V. D. Esker, C. Pathmamanoharan, and P. H. Wiersema, “Vesicles of variable diameter prepared by a modified injection method,” Biochemistry, vol. 16, no. 17, pp. 3932–3935, 1977. View at Google Scholar · View at Scopus
  33. B. Čeh and D. D. Lasic, “A rigorous theory of remote loading of drugs into liposomes: transmembrane potential and induced pH-gradient loading and leakage of liposomes,” Journal of Colloid and Interface Science, vol. 185, no. 1, pp. 9–18, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Imura, K. Otake, S. Hashimoto et al., “Preparation and physicochemical properties of various soybean lecithin liposomes using supercritical reverse phase evaporation method,” Colloids and Surfaces B, vol. 27, no. 3, pp. 133–140, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Otake, T. Imura, H. Sakai, and M. Abe, “Development of a new preparation method of liposomes using supercritical carbon dioxide,” Langmuir, vol. 17, no. 13, pp. 3898–3901, 2001. View at Google Scholar · View at Scopus
  36. X. D. Song, X. J. Wang, X. Du, H. Wei, D. Dong, and W. U. L. H, “Preparation of β-elemene liposome and their tissue distribution in rats,” Chinese Journal of New Drugs and Clinical Remedies, pp. 733–736, 2007. View at Google Scholar
  37. H. C. Huang, H. J. Zhu, and M. X. Zhang, “Preparative processing technique of β-elemene liposomes,” Chinese Traditional and Herbal Drugs, vol. 37, no. 12, pp. 1799–1802, 2006. View at Google Scholar · View at Scopus
  38. X. Du, X. D. Song, D. Dong, and L. H. Wu, “Study on the preparation and quality control of beta-elemene liposome,” Chinese Journal of Hospital Pharmacy, no. 12, 2007. View at Google Scholar
  39. X. Y. Zhang, X. M. Wang, Y. L. Hao, Y. Y. Wei, and X. F. Gao, “Optimal preparation of PVP-complexed β-elemene liposomes,” Chinese Journal of New Drugs, no. 3, 2006. View at Google Scholar
  40. X. P. Liu and W. C. Li, “Study on preparation technology of long-circulating β-elemene liposomes,” China Medical Herald, no. 23, 2010. View at Google Scholar
  41. X. Li, G. Wang, J. Zhao et al., “Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase,” Cellular and Molecular Life Sciences, vol. 62, no. 7-8, pp. 894–904, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Tao, L. Zhou, L. Zheng, and M. Yao, “Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo,” Cancer Chemotherapy and Pharmacology, vol. 58, no. 1, pp. 24–34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. J. W. Qi and W. Q. Liang, “Determination of β-elemene in sterically stabilized liposomes by HPLC,” Strait Pharmaceutical Journal, no. 10, 2008. View at Google Scholar
  44. S. D. Xie, X. Li, J. A. Feng, and X. Jin, “. Determination of content and entrapment efficiency of β-elemene lipsomes by uItrafiltration-GC,” China Pharmaceuticals, pp. 27–28, 2009. View at Google Scholar
  45. X. M. Wang, Y. J. Deng, Y. L. Hao, Y. Chen, H. J. Zhong, and C. J. Zhao, “Determination of entrapment efficiency of β-elemene liposome by minicolumn centrifugation-gas chromatography,” Journal of Shenyang Pharmaceutical University, no. 6, 2004. View at Google Scholar
  46. X. D. Song, H. M. Liu, H. Wei, D. Dong, and L. H. Wu, “Tissue distribution of β-elemene liposomes in rats,” Chinese Pharmaceutical Journal, vol. 42, no. 19, pp. 1480–1482, 2007. View at Google Scholar · View at Scopus
  47. L. H. Wu, X. D. Song, H. M. Liu et al., “Pharmacokinetic study of β-elemene liposome in rats,” Chinese Journal of Traditional Medical Science and Technology, vol. 14, no. 6, pp. 425–426, 2007. View at Google Scholar
  48. X. Y. Zhang, Y. J. Deng, C. J. Zhao, X. M. Wang, Z. Li, and X. F. Gao, “Study on pharmacokinetics of PVP coated beta-elemene liposome in rats,” Journal of Chinese Medicinal Materials, vol. 29, no. 2, pp. 157–160, 2006. View at Google Scholar · View at Scopus